छोड़कर सामग्री पर जाएँ

Cipla shares edge higher on large exchange volumes, hopes of better sales

  • द्वारा
  • Latest News

Cipla has been in the news recently after it signed a perpetual license agreement with Novartis Pharma AG to manufacture and market the Galvus range for the treatment of type 2 diabetes on April 10.

Read More

​ Cipla has been in the news recently after it signed a perpetual license agreement with Novartis Pharma AG to manufacture and market the Galvus range for the treatment of type 2 diabetes on April 10. Cipla has been in the news recently after it signed a perpetual license agreement with Novartis Pharma AG to manufacture and market the Galvus range for the treatment of type 2 diabetes on April 10.  Moneycontrol Latest News Read More  

Top 100 Best Sellers

प्रातिक्रिया दे

आपका ईमेल पता प्रकाशित नहीं किया जाएगा. आवश्यक फ़ील्ड चिह्नित हैं *

hi_INहिन्दी
en_USEnglish hi_INहिन्दी